Literature DB >> 7230728

Does chronic aspirin treatment increase blood pressure in man?

E Walter, W Kaufmann, P Oster.   

Abstract

In postmyocardial infarction patients longterm aspirin treatment with 1.5 g/day led to a significant increase in systolic and diastolic blood pressure after 6 months. This could not be found in the placebo- and the phenprocoumon-treated patients. After one year the blood pressure behaviour was the same in all three treatment groups. As nonsteroidal antirheumatic drugs can produce hypertension in animals, probably due to inhibition of prostaglandin synthesis, blood pressure control in longterm aspirin treatment is advisable.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7230728     DOI: 10.1007/bf01478209

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  12 in total

1.  Differential inhibition of prostacyclin production and platelet aggregation by aspirin.

Authors:  G Masotti; G Galanti; L Poggesi; R Abbate; G G Neri Serneri
Journal:  Lancet       Date:  1979-12-08       Impact factor: 79.321

Review 2.  Prostaglandins in circulatory disorders.

Authors:  J C McGiff
Journal:  Triangle       Date:  1979

3.  Dependency of renal blood flow on prostaglandin synthesis in the dog.

Authors:  A J Lonigro; H D Itskovitz; K Crowshaw; J C McGiff
Journal:  Circ Res       Date:  1973-06       Impact factor: 17.367

4.  [Function of thrombocytes in hemorrhagic diathesis, thrombosis and vascular diseases].

Authors:  K Breddin
Journal:  Thromb Diath Haemorrh Suppl       Date:  1968

5.  Aspirin and secondary mortality after myocardial infarction.

Authors:  P C Elwood; P M Sweetnam
Journal:  Lancet       Date:  1979 Dec 22-29       Impact factor: 79.321

6.  Prostaglandin biosynthesis in rabbit kidney medulla: inhibition in-vitro vs. in-vivo by aspirin, indomethacin and meclofenamic acid.

Authors:  Y Gafni; M Schwartzman; A Raz
Journal:  Prostaglandins       Date:  1978-05

7.  The effect of indomethacin blockade of prostaglandin synthesis on blood pressure of normal rabbits and rabbits with renovascular hypertension.

Authors:  J C Romero; C G Strong
Journal:  Circ Res       Date:  1977-01       Impact factor: 17.367

8.  Inhibition of platelet prostaglandin synthetase by oral aspirin.

Authors:  J W Burch; N Stanford; P W Majerus
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

9.  Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group.

Authors: 
Journal:  Circulation       Date:  1980-09       Impact factor: 29.690

10.  A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction.

Authors:  P C Elwood; A L Cochrane; M L Burr; P M Sweetnam; G Williams; E Welsby; S J Hughes; R Renton
Journal:  Br Med J       Date:  1974-03-09
View more
  5 in total

Review 1.  NSAIDs and blood pressure. Clinical importance for older patients.

Authors:  A G Johnson
Journal:  Drugs Aging       Date:  1998-01       Impact factor: 3.923

Review 2.  NSAIDs and increased blood pressure. What is the clinical significance?

Authors:  A G Johnson
Journal:  Drug Saf       Date:  1997-11       Impact factor: 5.606

Review 3.  Nonsteroidal anti-inflammatory drugs and hypertension. The risks in perspective.

Authors:  P W de Leeuw
Journal:  Drugs       Date:  1996-02       Impact factor: 9.546

4.  Arachidonic acid metabolites, hypertension and arteriosclerosis.

Authors:  P C Weber; W Siess; B Scherer; E Held; H Witzgall; R Lorenz
Journal:  Klin Wochenschr       Date:  1982-05-17

Review 5.  Antiplatelet agents and anticoagulants for hypertension.

Authors:  Gregory Yh Lip; Dirk C Felmeden; Girish Dwivedi
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.